Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 212

1.

A review of cinnabar (HgS) and/or realgar (As4S4)-containing traditional medicines.

Liu J, Wei LX, Wang Q, Lu YF, Zhang F, Shi JZ, Li C, Cherian MG.

J Ethnopharmacol. 2018 Jan 10;210:340-350. doi: 10.1016/j.jep.2017.08.037. Epub 2017 Aug 31. Review.

PMID:
28864167
2.

Basal and copper-induced expression of metallothionein isoform 1,2 and 3 genes in epithelial cancer cells: The role of tumor suppressor p53.

Ostrakhovitch EA, Song YP, Cherian MG.

J Trace Elem Med Biol. 2016 May;35:18-29. doi: 10.1016/j.jtemb.2016.01.008. Epub 2016 Jan 22.

PMID:
27049123
3.

Expression of functional metallothionein isoforms in papillary thyroid cancer.

Liu ZM, Hasselt CA, Song FZ, Vlantis AC, Cherian MG, Koropatnick J, Chen GG.

Mol Cell Endocrinol. 2009 Apr 10;302(1):92-8. doi: 10.1016/j.mce.2008.12.017. Epub 2009 Jan 20.

PMID:
19356627
4.

Polymorphisms in metallothionein-1 and -2 genes associated with the risk of type 2 diabetes mellitus and its complications.

Yang L, Li H, Yu T, Zhao H, Cherian MG, Cai L, Liu Y.

Am J Physiol Endocrinol Metab. 2008 May;294(5):E987-92. doi: 10.1152/ajpendo.90234.2008. Epub 2008 Mar 18.

5.

Metal complexes of dietary flavonoids: evaluation of radical scavenger properties and protective activity against oxidative stress in vivo.

Kostyuk VA, Potapovich AI, Kostyuk TV, Cherian MG.

Cell Mol Biol (Noisy-le-grand). 2007 Apr 15;53(1):62-9.

PMID:
17519113
6.

Induction of functional MT1 and MT2 isoforms by calcium in anaplastic thyroid carcinoma cells.

Liu ZM, Chen GG, Shum CK, Vlantis AC, Cherian MG, Koropatnick J, van Hasselt CA.

FEBS Lett. 2007 May 29;581(13):2465-72. Epub 2007 Apr 30.

7.

P53 mediated regulation of metallothionein transcription in breast cancer cells.

Ostrakhovitch EA, Olsson PE, von Hofsten J, Cherian MG.

J Cell Biochem. 2007 Dec 15;102(6):1571-83.

PMID:
17477370
8.

Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework.

Calabrese EJ, Bachmann KA, Bailer AJ, Bolger PM, Borak J, Cai L, Cedergreen N, Cherian MG, Chiueh CC, Clarkson TW, Cook RR, Diamond DM, Doolittle DJ, Dorato MA, Duke SO, Feinendegen L, Gardner DE, Hart RW, Hastings KL, Hayes AW, Hoffmann GR, Ives JA, Jaworowski Z, Johnson TE, Jonas WB, Kaminski NE, Keller JG, Klaunig JE, Knudsen TB, Kozumbo WJ, Lettieri T, Liu SZ, Maisseu A, Maynard KI, Masoro EJ, McClellan RO, Mehendale HM, Mothersill C, Newlin DB, Nigg HN, Oehme FW, Phalen RF, Philbert MA, Rattan SI, Riviere JE, Rodricks J, Sapolsky RM, Scott BR, Seymour C, Sinclair DA, Smith-Sonneborn J, Snow ET, Spear L, Stevenson DE, Thomas Y, Tubiana M, Williams GM, Mattson MP.

Toxicol Appl Pharmacol. 2007 Jul 1;222(1):122-8. Epub 2007 Mar 7. Review.

9.

Metallothionein expression as prognostic factor for transitional cell carcinoma of bladder.

Yamasaki Y, Smith C, Weisz D, van Huizen I, Xuan J, Moussa M, Stitt L, Hideki S, Cherian MG, Izawa JI.

Urology. 2006 Mar;67(3):530-5. Epub 2006 Feb 28.

PMID:
16504266
10.

Metallothionein and liver cell regeneration.

Cherian MG, Kang YJ.

Exp Biol Med (Maywood). 2006 Feb;231(2):138-44. Review.

PMID:
16446489
11.

Interaction of metallothionein with tumor suppressor p53 protein.

Ostrakhovitch EA, Olsson PE, Jiang S, Cherian MG.

FEBS Lett. 2006 Feb 20;580(5):1235-8. Epub 2006 Jan 20.

12.

Essentiality, toxicology and chelation therapy of zinc and copper.

Cai L, Li XK, Song Y, Cherian MG.

Curr Med Chem. 2005;12(23):2753-63. Review.

PMID:
16305470
13.

Zinc supplementation decreases hepatic copper accumulation in LEC rat: a model of Wilson's disease.

Gonzalez BP, Niño Fong R, Gibson CJ, Fuentealba IC, Cherian MG.

Biol Trace Elem Res. 2005 Summer;105(1-3):117-34.

PMID:
16034158
14.

Augmented hepatic injury followed by impaired regeneration in metallothionein-I/II knockout mice after treatment with thioacetamide.

Oliver JR, Jiang S, Cherian MG.

Toxicol Appl Pharmacol. 2006 Feb 1;210(3):190-9. Epub 2005 Jun 24.

PMID:
15979673
16.
17.
18.

Impaired hepatic regeneration in metallothionein-I/II knockout mice after partial hepatectomy.

Oliver JR, Mara TW, Cherian MG.

Exp Biol Med (Maywood). 2005 Jan;230(1):61-7.

PMID:
15618127
19.

Role of tumor necrosis factor-alpha in the development of spontaneous hepatic toxicity in Long-Evans Cinnamon rats.

Fong RN, Gonzalez BP, Fuentealba IC, Cherian MG.

Toxicol Appl Pharmacol. 2004 Oct 15;200(2):121-30.

PMID:
15476865
20.
21.
22.

Metallothioneins in human tumors and potential roles in carcinogenesis.

Cherian MG, Jayasurya A, Bay BH.

Mutat Res. 2003 Dec 10;533(1-2):201-9. Review.

PMID:
14643421
23.

Copper-binding proteins in human erythrocytes: searching for potential biomarkers of copper over-exposure.

Speisky H, Navarro P, Cherian MG, Jiménez I.

Biometals. 2003 Mar;16(1):113-23.

PMID:
12572671
25.

Endothelin-1-mediated alteration of metallothionein and trace metals in the liver and kidneys of chronically diabetic rats.

Cai L, Chen S, Evans T, Cherian MG, Chakrabarti S.

Int J Exp Diabetes Res. 2002 Jul-Sep;3(3):193-8.

26.
27.

The metallothionein-null phenotype is associated with heightened sensitivity to lead toxicity and an inability to form inclusion bodies.

Qu W, Diwan BA, Liu J, Goyer RA, Dawson T, Horton JL, Cherian MG, Waalkes MP.

Am J Pathol. 2002 Mar;160(3):1047-56.

28.

Mouse astrocyte cultures used to study antioxidant property of metallothionein isoforms.

Cherian MG, Suzuki Y, Apostolova M.

Methods Enzymol. 2002;348:337-42. No abstract available.

PMID:
11885288
29.

Reduction of copper and metallothionein in toxic milk mice by tetrathiomolybdate, but not deferiprone.

Czachor JD, Cherian MG, Koropatnick J.

J Inorg Biochem. 2002 Jan 15;88(2):213-22.

PMID:
11803042
30.

Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome.

Joseph MG, Banerjee D, Kocha W, Feld R, Stitt LW, Cherian MG.

Cancer. 2001 Aug 15;92(4):836-42.

PMID:
11550155
31.

Metallothionein in human gingival amalgam tattoos.

Lau JC, Jackson-Boeters L, Daley TD, Wysocki GP, Cherian MG.

Arch Oral Biol. 2001 Nov;46(11):1015-20.

PMID:
11543708
32.

Roles of vitamin C in radiation-induced DNA damage in presence and absence of copper.

Cai L, Koropatnick J, Cherian MG.

Chem Biol Interact. 2001 Jul 31;137(1):75-88.

PMID:
11518565
33.

High-glucose-induced metallothionein expression in endothelial cells: an endothelin-mediated mechanism.

Apostolova MD, Chen S, Chakrabarti S, Cherian MG.

Am J Physiol Cell Physiol. 2001 Sep;281(3):C899-907.

34.

Radiation exposure does not alter metallothionein III isoform expression in mouse brain.

Ono SI, Cai L, Koropatnick J, Cherian MG.

Biol Trace Elem Res. 2000 Apr;74(1):23-30.

PMID:
11049197
35.
36.

Metallothionein induction in human CNS in vitro: neuroprotection from ionizing radiation.

Cai L, Cherian MG, Iskander S, Leblanc M, Hammond RR.

Int J Radiat Biol. 2000 Jul;76(7):1009-17.

PMID:
10923625
37.

Induction of metallothionein synthesis with preservation of testicular function in rats following long term renal transplantation.

Cai L, Deng DX, Jiang J, Chen S, Zhong R, Cherian MG, Chakrabarti S.

Urol Res. 2000 Apr;28(2):97-103.

PMID:
10850631
38.

Effect of ethanol on brain metallothionein in transgenic mice.

Suzuki Y, Cherian MG.

Alcohol Clin Exp Res. 2000 Mar;24(3):315-21.

PMID:
10776668
39.

Nuclear localization of metallothionein during cell proliferation and differentiation.

Cherian MG, Apostolova MD.

Cell Mol Biol (Noisy-le-grand). 2000 Mar;46(2):347-56. Review.

PMID:
10774924
40.
41.

Repeated cadmium exposures enhance the malignant progression of ensuing tumors in rats.

Waalkes MP, Rehm S, Cherian MG.

Toxicol Sci. 2000 Mar;54(1):110-20.

PMID:
10746938
42.
43.
44.

Metallothionein and apoptosis during differentiation of myoblasts to myotubes: protection against free radical toxicity.

Apostolova MD, Ivanova IA, Cherian MG.

Toxicol Appl Pharmacol. 1999 Sep 15;159(3):175-84.

PMID:
10486304
45.

Endothelins and their receptors in cirrhotic and neoplastic livers of Canadian and Chinese populations.

Cai L, Wang GJ, Mukherjee K, Xu ZL, Khalil M, Cherian MG, Chakrabarti S.

Anticancer Res. 1999 May-Jun;19(3B):2243-7.

PMID:
10472337
46.

Metallothionein in radiation exposure: its induction and protective role.

Cai L, Satoh M, Tohyama C, Cherian MG.

Toxicology. 1999 Feb 15;132(2-3):85-98. Review.

PMID:
10433372
47.
48.

Increased radiation-induced apoptosis in mouse thymus in the absence of metallothionein.

Deng DX, Cai L, Chakrabarti S, Cherian MG.

Toxicology. 1999 May 3;134(1):39-49.

PMID:
10413187
49.

Metallothionein does not protect mouse endocrine cells from damage induced by alloxan injection.

Minami T, Shimizu M, Tanaka H, Okazaki Y, Cherian MG.

Toxicology. 1999 Jan 1;132(1):33-41.

PMID:
10199579
50.

Supplemental Content

Loading ...
Support Center